Three pathways for HCV-induced lymphomagenesis. (A) Chronic antigenic stimulation of a B cell that interacts through its surface Igs with the cognate HCV antigen. (B) HCV-E2 protein engaging its high-affinity receptor CD81 expressed on B cells. (C) Direct infection of a B cell by HCV.